RAP's Role in Amyloid Deposition in Alzheimer's Disease Mice
Author Information
Author(s): Xu Guilian, Karch Celeste, Li Ning, Lin Nianwei, Fromholt David, Gonzales Victoria, Borchelt David R.
Primary Institution: University of Florida
Hypothesis
How does the reduction of receptor-associated protein (RAP) influence amyloid deposition in APP/PS1 transgenic mice?
Conclusion
Reducing RAP levels leads to increased amyloid deposition in a mouse model of Alzheimer's disease.
Supporting Evidence
- Partial reductions in RAP levels were associated with a 30-40% increase in amyloid deposition.
- Immunoblot analysis showed a 15% reduction in SorLA/LR11 levels with reduced RAP.
- Statistical analysis indicated a significant difference in amyloid burden between the genotypes.
Takeaway
When we lower the amount of a protein called RAP in mice, they end up with more sticky stuff in their brains that can cause Alzheimer's disease.
Methodology
Transgenic mice were used to study the effects of RAP reduction on amyloid deposition, with various biochemical and histological analyses performed.
Potential Biases
Potential bias due to the different genetic backgrounds of the mouse models compared.
Limitations
The study's findings may be influenced by genetic background differences between the mouse strains used.
Participant Demographics
Mice used were transgenic for APP and PS1, with some having a homozygous deletion of RAP.
Statistical Information
P-Value
p<0.025
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website